Loek  Eggermont

Loek  Eggermont

Eggermont Loek

Loek Eggermont obtained his master's degree in Molecular Life Sciences at the Radboud University Nijmegen in 2013. During his master's, he performed internships concerning bioorthogonal chemistry, chemical biology and biochemistry. In August 2013, he joined the Department of Tumor Immunology as a PhD student to work on the development of synthetic dendritic cells for improved cancer immunotherapies.